GTx Framed Oncternal Takeover As Acquisition, Investors Say
Shareholders of GTx Inc. were fooled by company executives into thinking the biopharmaceutical company was taking over Oncternal Therapeutics in a planned merger when in reality it was the other way...To view the full article, register now.
Already a subscriber? Click here to view full article